How Does Sotera Health Co (SHC) Stock Rank on Wall Street Monday?

Wall Street is positive on Sotera Health Co (SHC). On average, analysts give Sotera Health Co a Buy rating. The average price target is $18, which means analysts expect the stock to add by 50.75% over the next twelve months. That average ranking earns Sotera Health Co an Analyst Rating of 20, which is better than 20% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating SHC a Buy today. Find out what this means to you and get the rest of the rankings on SHC!

See Full SHC Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Sotera Health Co Stock Today?

Sotera Health Co (SHC) stock is higher by 5.62% while the S&P 500 has fallen -0.21% as of 12:51 PM on Monday, Mar 25. SHC has risen $0.64 from the previous closing price of $11.30 on volume of 1,080,297 shares. Over the past year the S&P 500 is up 31.31% while SHC has fallen -31.93%. SHC earned $0.18 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 66.17. Click Here to get the full Stock Report for Sotera Health Co stock.